Adar Poonawalla's Serum Institute Told To Pause Vaccine Trial Recruitment
PUBLISHED ON: September 12, 2020 | Duration: 0 min, 57 sec
New recruitment for the Phase 2 and Phase 3 trials of the Oxford University's Covishield vaccine being manufactured in India by the Serum Institute of India, along with pharma major AstraZeneca, has to be suspended till further orders, country's drug controller DGCI has said.
